B`orze Inc Laser Family (Sorren/Adonis)
Borze, Inc. · Decision date Oct 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 10/30/2026 for K263063, submitted by Borze, Inc. of Boise, Idaho, covering the device named B`orze Inc Laser Family (Sorren/Adonis). The application was received 09/01/2026 and listed as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The classification is Powered Laser Surgical Instrument under regulation 878.4810, product code GEX, in the General & Plastic Surgery specialty and review panel.
SESE in a 510(k) means the device was found substantially equivalent to a legally marketed predicate and cleared to market; it is not a PMA approval. The public record identifies Shenzhen Hlongmed Biotech Co., Ltd. as correspondent, with Long Yang as correspondent contact. The record does not state which laser components, models, or specific changes were assessed, nor the predicate device, so the technical basis for equivalence remains unknown from these fields.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263063
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Borze, Inc.
- Product code
- GEX
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Laser Surgical Instrument.
- Applicant
- Borze, Inc.
- Product code
- GEX
- FDA device class
- 2
FDA decision timeline
K263063 received
Application receipt date recorded by FDA.
K263063 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Single Use Optical FiberK262886 | Quanta System Spa | 510(k) clearance | Nov 5, 2026 | FDA |
| Risu Medical Technology Co., Ltd. | 510(k) clearance | Oct 27, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Beijing Sea Heart International Science and Technologyco.Ltd | 510(k) clearance | Oct 22, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 20, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Borze, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Boise, ID
Sources and methodology
- Original FDA record: K263063
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


